No, not all STIs can be cured; many bacterial STIs clear with the right medicine, while several viral STIs stay in the body and are managed.
If you just got a test result, you’re probably hunting for one thing: “Can I get rid of this for good?” The honest answer depends on the germ. Some sexually transmitted infections clear fully after antibiotics. Others can’t be erased, yet they can be controlled so well that symptoms fade, complications drop, and passing it on becomes less likely.
You’ll learn which STIs are curable, which ones are treatable but persistent, and what “managed” means in day-to-day life. You’ll also get a practical plan for the weeks after a diagnosis, plus prevention moves that cut the odds of reinfection.
Can All STIs Be Cured? What “Cure” Means In Real Terms
People use the word “cure” in two different ways. Clinicians usually mean the infection is cleared from the body after treatment, with no ongoing virus or bacteria left behind. Many readers mean “I feel fine again.” Those aren’t the same.
A clear example is herpes. You can go long stretches with no sores and feel normal. That’s symptom control, not eradication. With chlamydia, treatment can clear the bacteria, and follow-up testing can confirm the infection is gone. That’s closer to what most people mean by a cure.
Why the type of germ changes the answer
Bacteria and parasites are often cured because medicines can eliminate them. Viruses behave differently. They can hide inside cells or stay quiet for long periods. That’s why the “curable vs manageable” split often lines up with “bacterial vs viral.” The World Health Organization groups four common STIs as curable (syphilis, gonorrhoea, chlamydia, trichomoniasis) and four as viral (hepatitis B, HSV, HIV, HPV). WHO STI fact sheet gives that overview.
Curable vs treatable STIs: The difference that matters day to day
A curable STI usually means: take the prescribed medicine, avoid sex until treatment is complete, and confirm clearance when advised. A treatable-but-persistent STI often means: manage symptoms, protect partners, and stick with follow-up.
Both paths can end with a healthy sex life. The difference is what you keep watching. Curable infections are often about preventing reinfection. Persistent infections are about keeping the germ suppressed, spotting flare-ups early, and lowering long-term risks.
Why some STIs don’t go away after treatment
Viruses can stay inside nerve tissue (HSV), inside immune cells (HIV), or in skin and mucosal tissue (HPV). They can be quiet, then reactivate. Medicine can still do a lot, yet it works by control, not removal.
For HIV, treatment is called antiretroviral therapy (ART). ART can’t cure HIV, yet it can help people live long lives and reduce the risk of transmission. NIH HIV treatment basics explains how ART lowers viral load and why staying on treatment matters.
HPV is another place people get tripped up. Many HPV infections clear on their own, yet there isn’t a treatment that guarantees clearance on a set date. Prevention is where the big win sits: vaccination blocks the HPV types most tied to cancer. CDC HPV vaccination explains recommendations and timing.
What causes “still positive” results after treatment
Seeing a positive test again can feel like treatment failed. Several different things can be going on.
Reinfection from an untreated partner
This is common with chlamydia and gonorrhea. If a partner doesn’t get treated, you can pass the infection back and forth. Treating partners at the same time and avoiding sex until treatment is finished reduces that risk.
Testing at the wrong time
Some tests can pick up leftover genetic material soon after treatment. Your clinic can tell you when retesting makes sense for your situation.
Resistance or missed doses
For some infections, resistance is real, and missed doses can lower the chance of clearance. If symptoms persist, report what you took, when you took it, and whether any doses were missed.
Table: Which common STIs are curable and what treatment usually targets
The chart below is a plain-language snapshot. Treatment choices depend on test results, symptoms, allergies, pregnancy status, and local resistance patterns. Many clinicians use the CDC STI Treatment Guidelines to choose regimens and follow-up steps.
| Infection | Curable? | Typical treatment or management |
|---|---|---|
| Chlamydia | Yes | Antibiotics; prevent reinfection; retesting in select cases |
| Gonorrhea | Yes | Antibiotic treatment chosen to match guidance and resistance patterns |
| Syphilis | Yes | Antibiotics; staged follow-up with blood tests |
| Trichomoniasis | Yes | Antiparasitic medicine; partner treatment to prevent repeat infection |
| Mycoplasma genitalium | Often | Antibiotics may clear it; resistance can make treatment longer or staged |
| Genital herpes (HSV-1/HSV-2) | No | Antiviral medicine for outbreaks or daily suppression; safer-sex steps |
| HIV | No | Antiretroviral therapy to maintain viral suppression |
| HPV | No | Immune clearance is common; screening and treatment for cell changes |
| Hepatitis B | No | Monitoring; antiviral treatment for chronic infection in some cases |
What to do in the first month after a diagnosis
The first month is about three things: treat what’s treatable, protect partners, and make a follow-up plan you can stick with.
Week 1: Lock down the basics
- Ask for the exact infection name and the test site (urine, throat, rectum, blood).
- Start treatment right away and finish every dose.
- Pause sex until the clinic says it’s safe.
- Tell recent partners so they can get tested and treated.
Week 2: Check symptoms and tighten prevention
If symptoms were present, you should see steady improvement. If pain, fever, new rash, eye pain, or swelling shows up, contact a clinician promptly. If you’re pregnant, flag any STI result to your prenatal team right away.
This is also a good time to set up prevention habits that match your life: condoms that fit, lubricant to reduce breakage, and a decision on how often you’ll screen.
Weeks 3–4: Follow the retest plan
Retesting is not “one size fits all.” Some infections call for a test-of-cure in certain situations. Others call for retesting later to catch reinfection. Ask your clinic for a date, not a vague window, and put it on your calendar.
Living with an STI that can’t be cured
Hearing “no cure” can hit hard. Many people still end up with a normal routine, with a few extra habits.
Herpes: fewer surprises
Antiviral medicines can shorten outbreaks and, for many people, reduce how often outbreaks happen. People also get better at spotting early warning signs and start treatment early. Between outbreaks, many feel completely fine.
HPV: screening keeps you ahead of problems
HPV is common. Most infections clear, yet certain high-risk types can cause cell changes over time. Follow the screening schedule you’re given, and don’t skip follow-up procedures if they’re recommended.
HIV: treatment is long-term, life is still broad
With ART, many people reach viral suppression and stay there. That lowers the risk of complications and reduces the chance of passing HIV to others. Staying on treatment and keeping lab appointments is the core habit.
Prevention moves that actually cut risk
Use barriers with intention
Condoms and dental dams reduce risk for many STIs. They work best when used from start to finish and replaced if they tear.
Use vaccines where they fit
HPV vaccination prevents many infections, and hepatitis B vaccination prevents another sexually transmitted virus. Ask a clinic to check your vaccine history if you’re unsure.
Make testing routine
Many STIs cause no symptoms early on. Routine screening finds silent infections. Ask what sites should be tested based on the sex you have.
Table: A practical follow-up plan after treatment
This table is built for real life. Use it as a checklist for your next clinic visit or telehealth call.
| Situation | Next step | What it prevents |
|---|---|---|
| Curable STI treated, no symptoms now | Ask if retesting is advised and when; avoid sex until cleared | Repeat infection and early spread |
| Symptoms continue after finishing medicine | Return for reevaluation; report all doses and timing | Ongoing infection or wrong diagnosis |
| New partner or multiple partners | Set a screening schedule based on risk and site | Silent infections that cause later harm |
| Herpes diagnosed | Ask about episodic vs daily antiviral use | Frequent outbreaks and partner transmission |
| HIV diagnosed | Start ART promptly and keep lab follow-up | Immune damage and onward transmission |
| HPV-related abnormal screening | Follow the repeat test or procedure schedule | Missed precancer changes |
| Trying to conceive or pregnant | Tell your prenatal team and follow pregnancy-specific rules | Complications for parent and baby |
Common myths that lead to bad decisions
“If I don’t have symptoms, I’m fine”
Many infections are silent. Screening is how you find them.
“If the symptoms stopped, I’m cured”
Symptoms can fade before an infection clears. Finish treatment, then follow the clinic’s rule on waiting before sex and whether retesting is needed.
“Only certain people get STIs”
STIs follow behavior, not identity. If you have sex, you can get one.
A short checklist to bring to your next appointment
- Exact test result and specimen site
- Medicine name, dose, and dates taken
- Symptoms that changed, plus what day they changed
- Partner notification status
- Planned retest date, if advised
- Questions about vaccines, screening, and barriers
References & Sources
- World Health Organization (WHO).“Sexually transmitted infections (STIs).”Summarizes common STI pathogens and notes which are curable versus viral.
- NIH HIVinfo (U.S. Department of Health and Human Services).“HIV Treatment: The Basics.”Explains ART, viral suppression, and why ongoing treatment reduces transmission risk.
- Centers for Disease Control and Prevention (CDC).“HPV Vaccination.”Describes HPV vaccine recommendations and how vaccination prevents HPV infections linked to cancer.
- Centers for Disease Control and Prevention (CDC).“Sexually Transmitted Infections Treatment Guidelines, 2021.”Evidence-based treatment and follow-up guidance used by clinicians for STI care.